Federal and UK cyber agencies warn that unsupported routers, firewalls and VPNs are being targeted by nation‑state actors. Local IT teams should inventory, patch or replace at‑risk gear.

Former WBIR anchor Abby Ham says sexually explicit deepfakes of her surfaced online. Experts and regulators say the problem is escalating and legal tools are being updated.

Halozyme raised 2026 guidance and acquired two hyperconcentration firms, projecting faster royalty growth and several clinic starts that could reshape local drug‑delivery work.

Researchers found airline and hotel loyalty accounts being traded on dark‑web forums, sometimes for pennies. Experts urge unique passwords, MFA and close account checks.

A randomized national trial that included Austin sites found a midpregnancy blood test plus a short care bundle cut the earliest preterm births and reduced NICU time.

Ohio State University researchers created RNA micelles for targeted chemotherapy delivery to treat metastatic colorectal cancer, showing promising results in mice.

Zucker Hillside Hospital has initiated a study observing participants use substances like alcohol, cannabis, psilocybin, and MDMA to understand their therapeutic potential and risks.

Austin drone maker Skyways is pushing from test flights to a Tech Ridge production push and expects to double local staff as defense awards and policy shifts ramp demand.

FIRST extended its partnership with Houston through 2034, a seven-year agreement tied to the George R. Brown expansion that officials say will bring thousands and more than $500 million to the city.

Coherent secured a $14.08M TSIF award to ramp six‑inch indium phosphide wafer production in Sherman, Texas. The project is tied to more than $154M in planned investment.

Fort Worth startup Element3 says it will extract battery‑grade lithium from Permian produced water at a Midland plant, a move that could revive U.S. lithium production. Local reporting and company releases say commercial units will be installed in early 2026.

Angi will cut about 350 jobs, saying AI‑driven efficiency makes parts of its operation redundant. Company filings estimate $22M–$30M in charges and $70M–$80M in annual savings.

Clinical trial results indicate a protein, rFVIIa, may benefit certain stroke patients when administered quickly, with a focus on acute intracerebral hemorrhage treatments.